Zobrazeno 1 - 10
of 39
pro vyhledávání: '"KL Komschlies"'
Autor:
K Grzegorzewski, KL Komschlies, M Mori, K Kaneda, N Usui, CR Faltynek, JR Keller, FW Ruscetti, RH Wiltrout
Publikováno v:
Blood. 83(2)
The administration of recombinant human interleukin-7 (rhIL-7) to mice twice a day for 7 days does not appreciably change bone marrow (BM) cellularity, but does result in a threefold to fivefold increase in the total number of leukocytes in the splee
Publikováno v:
Blood. 79(5)
The administration of greater than or equal to 5 micrograms interleukin- 7 (IL-7) twice a day to mice for 4 to 7 days increased by twofold to fivefold the total number of splenic and peripheral blood leukocytes, but did not appreciably increase bone
Autor:
Ha, Young, Kl, Komschlies, Ciccarone V, Beckwith M, Rosenberg M, Na, Jenkins, Ng, Copeland, scott durum
Publikováno v:
Europe PubMed Central
We have introduced an 8.6-kb fragment of human genomic DNA containing the full length IFN-gamma gene into the mouse germline. The transgenic animals had no biologic or developmental defects as human IFN-gamma does not bind to the mouse IFN R. Regulat
Autor:
Abe K; Laboratory of Molecular Immunoregulation, Center for Cancer Research and Basic Research Program, SAIC Frederick, National Cancer Institute, MD 21702, USA., Yarovinsky FO, Murakami T, Shakhov AN, Tumanov AV, Ito D, Drutskaya LN, Pfeffer K, Kuprash DV, Komschlies KL, Nedospasov SA
Publikováno v:
Blood [Blood] 2003 Feb 15; Vol. 101 (4), pp. 1477-83.
Autor:
Shimozato O; Laboratory of Experimental Immunology, Center for Cancer Research, and Intramural Research Support Program, Science Applications International Corp.-Frederick, National Cancer Institute, Frederick, MD 21702, USA., Ortaldo JR, Komschlies KL, Young HA
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2002 Feb 15; Vol. 168 (4), pp. 1746-52.
Autor:
Lee JK; Laboratory of Experimental Immunology, National Cancer Institute-Frederick, Frederick, MD, USA., Back TC, Komschlies KL, Ruscetti FW, Young HA, Wiltrout RH
Publikováno v:
In vivo (Athens, Greece) [In Vivo] 2001 Jul-Aug; Vol. 15 (4), pp. 255-63.
Autor:
Wigginton JM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gruys E, Geiselhart L, Subleski J, Komschlies KL, Park JW, Wiltrout TA, Nagashima K, Back TC, Wiltrout RH
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2001 Jul; Vol. 108 (1), pp. 51-62.
Autor:
Fry TJ; Molecular Oncology Section, Pediatric Branch, National Cancer Institute, National Institutes of Heath, Bethesda, Maryland, USA. tf60y@nih.gov, Christensen BL, Komschlies KL, Gress RE, Mackall CL
Publikováno v:
Blood [Blood] 2001 Mar 15; Vol. 97 (6), pp. 1525-33.
Autor:
Geiselhart LA; Laboratory of Experimental Immunology, Division of Basic Sciences, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA., Humphries CA, Gregorio TA, Mou S, Subleski J, Komschlies KL
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2001 Mar 01; Vol. 166 (5), pp. 3019-27.
Autor:
Welniak LA; Laboratory of Leukocyte Biology, Division of Basic Sciences, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA., Khaled AR, Anver MR, Komschlies KL, Wiltrout RH, Durum S, Ruscetti FR, Blazar BR, Murphy WJ
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2001 Mar 01; Vol. 166 (5), pp. 2924-8.